scientist at work

Platforms and technology

stem cell reprogramming
Stem Cell Biology and Regenerative Medicine

The Institutional Stem Cell Core has been discontinued, with the functions of the former Core now split into two separate operations:

- iPSCs

- Shared Laboratory

Learn more

Bioinformatics and Structural Biology Program

Where do new medicines come from? In the past, large pharmaceutical companies were solely responsible for most drug discovery. Due to high costs and pressures to “fill the pipeline” faster, pharmaceutical companies frequently move away from drug discovery efforts that are deemed risky, especially for “orphan” diseases that are unprofitable for investors. In 2005, the National Institutes of Health announced a 9-year initiative to bridge the gap between basic research carried out in academic research laboratories and FDA approval of new medicines.

Learn more

"NIH grant HIV AIDS vaccine" image